403 related articles for article (PubMed ID: 34203510)
1. Optimizing Antimicrobial Drug Dosing in Critically Ill Patients.
Póvoa P; Moniz P; Pereira JG; Coelho L
Microorganisms; 2021 Jun; 9(7):. PubMed ID: 34203510
[TBL] [Abstract][Full Text] [Related]
2. Multidrug Resistance in Critically Ill Patients: An Unresolved Issue.
Spadaro S
Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110369
[TBL] [Abstract][Full Text] [Related]
3. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
4. Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.
Phe K; Heil EL; Tam VH
J Infect Dis; 2020 Jul; 222(Suppl 2):S132-S141. PubMed ID: 32691832
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
Varghese JM; Roberts JA; Lipman J
Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill.
Tsai D; Lipman J; Roberts JA
Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420
[TBL] [Abstract][Full Text] [Related]
7. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
8. Optimizing antimicrobial therapy in critically ill patients.
Vitrat V; Hautefeuille S; Janssen C; Bougon D; Sirodot M; Pagani L
Infect Drug Resist; 2014; 7():261-71. PubMed ID: 25349478
[TBL] [Abstract][Full Text] [Related]
9. Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
Jang SM; Infante S; Abdi Pour A
Pharmacy (Basel); 2020 Feb; 8(1):. PubMed ID: 32046092
[TBL] [Abstract][Full Text] [Related]
10. Plasma pharmacokinetics of antimicrobial agents in critically ill patients.
Pea F
Curr Clin Pharmacol; 2013 Feb; 8(1):5-12. PubMed ID: 22946868
[TBL] [Abstract][Full Text] [Related]
11. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
Blot S; Lipman J; Roberts DM; Roberts JA
Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
[TBL] [Abstract][Full Text] [Related]
12. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
[TBL] [Abstract][Full Text] [Related]
13. Physiological changes in the critically ill patient with sepsis.
Hosein S; Udy AA; Lipman J
Curr Pharm Biotechnol; 2011 Dec; 12(12):1991-5. PubMed ID: 21554219
[TBL] [Abstract][Full Text] [Related]
14. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
Blot SI; Pea F; Lipman J
Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
Pea F; Viale P; Furlanut M
Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
[TBL] [Abstract][Full Text] [Related]
16. Individualized precision dosing approaches to optimize antimicrobial therapy in pediatric populations.
Tu Q; Cotta M; Raman S; Graham N; Schlapbach L; Roberts JA
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1383-1399. PubMed ID: 34313180
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients.
Kovačević T; Avram S; Milaković D; Špirić N; Kovačević P
J Basic Clin Pharm; 2016 Jun; 7(3):65-9. PubMed ID: 27330257
[TBL] [Abstract][Full Text] [Related]
18. β-Lactam Dosing in Critical Patients: A Narrative Review of Optimal Efficacy and the Prevention of Resistance and Toxicity.
Pereira JG; Fernandes J; Duarte AR; Fernandes SM
Antibiotics (Basel); 2022 Dec; 11(12):. PubMed ID: 36551496
[TBL] [Abstract][Full Text] [Related]
19. Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial Dosing.
Chiriac U; Richter DC; Frey OR; Röhr AC; Helbig S; Preisenberger J; Hagel S; Roberts JA; Weigand MA; Brinkmann A
Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34205135
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit.
Williams P; Cotta MO; Roberts JA
Semin Respir Crit Care Med; 2019 Aug; 40(4):476-487. PubMed ID: 31585474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
